Effects of Immunotherapy: Clinical Trials

2 trials for Effects of Immunotherapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown. 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Unknown 2
Phase 22Unknown 2

Follow Effects of Immunotherapy: new trials by email Literature Review of Effects of Immunotherapy trials Research Report on Effects of Immunotherapy

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
TIL and Anti-PD1 in Metastatic Melanoma
Nivolumab & Tumor Infiltrating Lymphocytes with/without Interferon-Alpha - Toxicity, Drug, Adverse Drug Event
Phase 1 / Phase 2UnknownLeiden University342018-07-312023-12-12
Safety and Immunogenicity of Recombinant WT1 Antigen-Specific Cancer Immunotherapeutic Combined With Infusion of Treg Depleted T Cells for Adult WT1 Acute Myeloid Leukemia
Recombinant WT1 Antigen-Specific Cancer Immunotherapeutic (ASCI) - Acute Myelogenous Leukemia, Myeloid Leukemia in Remission
Phase 1 / Phase 2UnknownJules Bordet Institute202011-12-012012-01-20

Narrower conditions

Drug-Related Side Effects and Adverse Reactions (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Melanoma (1)

Broader conditions

Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Chemically-Induced Disorders (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Leukemia (1)  ·  Leukemia, Myeloid (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Germ Cell and Embryonal (1)  ·  Neoplasms, Nerve Tissue (1)  ·  Neuroectodermal Tumors (1)  ·  Neuroendocrine Tumors (1)  ·  Nevi and Melanomas (1)  ·  Skin Diseases (1)  ·  Skin Neoplasms (1)

Interventions

Nivolumab (1)

Sponsors

Jules Bordet Institute (1)  ·  Leiden University (1)

Countries

Belgium (1)  ·  Netherlands (1)

Top investigators

Ellen Kapiteijn, Dr. (1)  ·  Philippe Martiat, MD PhD (1)

Results publications

PMID 33234662